Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Radius Health, Inc. (RDUS)
Sector: Healthcare; Industry: Drug Manufacturers—Specialty & Generic

Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Eisai Co. Ltd.; Duke University; and Teijin Limited.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-01-06 BIOTECH TARGET N V 10%-Owner Buy 550,000 $6.31 $3,469,060 No
2021-09-29 BIOTECH TARGET N V 10%-Owner Buy 100,000 $12.95 $1,294,500 No
2021-09-22 BIOTECH TARGET N V 10%-Owner Buy 150,000 $12.28 $1,841,280 No
2020-11-05 BIOTECH TARGET N V 10%-Owner Buy 100,000 $14.26 $1,426,230 No
2020-09-14 BIOTECH TARGET N V 10%-Owner Buy 200,000 $11.69 $2,338,680 No
2020-09-11 BIOTECH TARGET N V 10%-Owner Buy 199,029 $11.33 $2,255,118 No
2020-07-08 BIOTECH TARGET N V 10%-Owner Buy 25,000 $13.21 $330,178 No
2020-04-30 BIOTECH TARGET N V 10%-Owner Buy 50,000 $15.75 $787,555 No

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.

Insider Smart

PROSPECT CAPITAL CORP (PSEC) - PSEC is the 2nd most bought stock of the past 90 days by insiders, CEO seems very confident about the company.